Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines.
Gambardella J, Santulli G, Fiordelisi A, Cerasuolo FA, Wang X, Prevete N, Sommella E, Avvisato R, Buonaiuto A, Altobelli GG, Rinaldi L, Chiuso F, Feliciello A, Dal Piaz F, Campiglia P, Ciccarelli M, Morisco C, Sadoshima J, Iaccarino G, Sorriento D. Gambardella J, et al. Among authors: campiglia p. Cell Mol Life Sci. 2023 Oct 11;80(11):323. doi: 10.1007/s00018-023-04922-5. Cell Mol Life Sci. 2023. PMID: 37819449 Free PMC article.
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B, Bendinelli S, Gabelloni P, Da Pozzo E, Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C. Costa B, et al. Among authors: campiglia p. PLoS One. 2013 Aug 19;8(8):e72281. doi: 10.1371/journal.pone.0072281. eCollection 2013. PLoS One. 2013. PMID: 23977270 Free PMC article.
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors.
Carotenuto A, Cipolletta E, Gomez-Monterrey I, Sala M, Vernieri E, Limatola A, Bertamino A, Musella S, Sorriento D, Grieco P, Trimarco B, Novellino E, Iaccarino G, Campiglia P. Carotenuto A, et al. Among authors: campiglia p. Eur J Med Chem. 2013 Nov;69:384-92. doi: 10.1016/j.ejmech.2013.08.039. Epub 2013 Sep 13. Eur J Med Chem. 2013. PMID: 24077529
Novel therapeutic targets in metabolic disorders: from the bench to the bedside.
Illario M, Di Somma C, Iaccarino G, Campiglia P, Sankar U, Montuori N. Illario M, et al. Among authors: campiglia p. ScientificWorldJournal. 2014;2014:365974. doi: 10.1155/2014/365974. Epub 2014 May 13. ScientificWorldJournal. 2014. PMID: 24959610 Free PMC article. No abstract available.
CaMKII protects MKP-1 from proteasome degradation in endothelial cells.
Ciccarelli M, Rusciano MR, Sorriento D, Basilicata MF, Santulli G, Campiglia P, Bertamino A, De Luca N, Trimarco B, Iaccarino G, Illario M. Ciccarelli M, et al. Among authors: campiglia p. Cell Signal. 2014 Oct;26(10):2167-74. doi: 10.1016/j.cellsig.2014.06.009. Epub 2014 Jul 5. Cell Signal. 2014. PMID: 25007998
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy.
Cipolletta E, Rusciano MR, Maione AS, Santulli G, Sorriento D, Del Giudice C, Ciccarelli M, Franco A, Crola C, Campiglia P, Sala M, Gomez-Monterrey I, De Luca N, Trimarco B, Iaccarino G, Illario M. Cipolletta E, et al. Among authors: campiglia p. PLoS One. 2015 Jun 25;10(6):e0130477. doi: 10.1371/journal.pone.0130477. eCollection 2015. PLoS One. 2015. PMID: 26110816 Free PMC article.
258 results